Shen Qi-Hong, Li Hui-Fang, Zhou Xuyan, Lu Yaping, Yuan Xiao-Zong
Anesthesiology, First Hospital of Jiaxing, Affiliated Hospital of Jiaxing University, Jiaxing, China
Gynecology, Tongxiang Maternal And Child Health Care Hospital, Tongxiang, China.
BMJ Open. 2020 Oct 5;10(10):e038293. doi: 10.1136/bmjopen-2020-038293.
Perioperative shivering (POS) is a common complication in patients undergoing spinal anaesthesia. The present study investigated the efficacy of 5-HT receptor antagonists in preventing POS following spinal anaesthesia.
Systematic review and meta-analysis.
Pubmed, Embase, the Web of Science and Cochrane Library were searched from database establishment on 31 July 2019.
Randomised controlled trials that reported the effects of 5-HT receptor antagonists in the prevention of POS in patients after spinal anaesthesia.
Two reviewers independently extracted data. The primary outcome of the present study was the incidence of POS. The risk of bias for the included studies was assessed according to the Cochrane Handbook. The quality of primary outcome was evaluated by Grading of Recommendations Assessment, Development and Evaluation. Trial sequential analysis for the primary outcome was performed to reduce the type 1 error caused by repeated meta-analysis and the required information size was calculated.
A total of 13 randomised controlled trials consisting of 1139 patients were included. The overall incidence of POS was significantly lower in the 5-HT receptor antagonists group (risk ratio 0.31; 95% CI 0.26 to 0.38; p<0.01; I=0%). Subgroup analysis for different types of 5-HT receptor antagonists and timing of administration produced similar results. Also, patients had a lower incidence of postoperative nausea and vomiting after administrating 5-HT3 receptor antagonists. No statistically significant differences in drug-related adverse effects were observed. Grading of Recommendations Assessment, Development and Evaluation revealed a high level of evidence. The cumulative z-curve crossed the trial sequential monitoring boundary.
The present study revealed that prophylactic 5-HT receptor antagonists were an effective measure for reducing the incidence of POS in patients after spinal anaesthesia. However, further studies investigating the different types of surgeries are required.
CRD42019148191.
围手术期寒战(POS)是接受脊髓麻醉患者的常见并发症。本研究调查了5-羟色胺(5-HT)受体拮抗剂预防脊髓麻醉后POS的疗效。
系统评价和荟萃分析。
检索了2019年7月31日数据库建立以来的PubMed、Embase、科学网和Cochrane图书馆。
报告5-HT受体拮抗剂对脊髓麻醉后患者预防POS效果的随机对照试验。
两名评价员独立提取数据。本研究的主要结局是POS的发生率。根据Cochrane手册评估纳入研究的偏倚风险。通过推荐分级评估、制定和评价对主要结局的质量进行评估。对主要结局进行试验序贯分析以减少重复荟萃分析导致的I类错误,并计算所需信息大小。
共纳入13项随机对照试验,包括1139例患者。5-HT受体拮抗剂组POS的总体发生率显著较低(风险比0.31;95%CI 0.26至0.38;p<0.01;I²=0%)。对不同类型5-HT受体拮抗剂和给药时间的亚组分析产生了相似的结果。此外,患者服用5-HT3受体拮抗剂后术后恶心呕吐的发生率较低。未观察到与药物相关不良反应的统计学显著差异。推荐分级评估、制定和评价显示证据水平较高。累积z曲线越过了试验序贯监测边界。
本研究表明,预防性使用5-HT受体拮抗剂是降低脊髓麻醉后患者POS发生率的有效措施。然而,需要进一步研究不同类型的手术。
PROSPERO注册号:CRD42019148191。